Net income
−$110.3M
+43.8% vs prior year
EPS, diluted
−$1.02
+82.1% vs prior year
Operating cash flow
−$99.2M
+39.5% vs prior year
Operating income
−$125.4M
+35.9% vs prior year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY22 | −$110.3M |
| FY21 | −$196.3M |
| FY20 | −$139.6M |
| FY19 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY22 | −$101M |
| FY21 | −$164.9M |
| FY20 | −$99M |
| FY19 | - |
News
No stories filed under LianBio yet - coverage appears here as the news feed clusters it.